Back

Health Surveillance And Epidemiological Profile Of Severe Acute Respiratory Syndrome Due To COVID-19 In Brazil (2020-2024)

Candido-Sobrinho, S. A.; Silva-Filho, J. Q. d.; Junior, F. d. S.; Feitosa Viana, V. A.; Moreira Lima, A. A.

2025-04-28 public and global health
10.1101/2025.04.27.25326529 medRxiv
Show abstract

WHAT WAS ALREADY KNOWN?O_LIVariants influence COVID-19 severity: Variants such as Delta and Gamma were already associated with increased transmissibility and lethality. C_LIO_LIVaccination has a protective role against severe forms of the disease: Previous data showed reduced mortality with vaccines, especially after completing the primary series. C_LIO_LIRegional inequalities impact outcomes: Regions with lower healthcare infrastructure, especially in the North and Northeast, face higher fatality rates. C_LI WHAT IS NEW?O_LIThree major waves of SARS due to COVID-19, with marked differences by region and variant: The second wave was the deadliest, and Omicron, though less pathogenic, had widespread circulation and three distinct peaks. C_LIO_LIDirect impact of sociodemographic and economic factors on outcomes: Lethality was higher among illiterate individuals, Black and Brown populations, and rural residents. C_LIO_LIRobust effect of booster vaccination on survival: Individuals with a first or second booster were up to 60% less likely to die and had four times higher survival at 40 days compared to unvaccinated individuals. C_LI The COVID-19 crisis exposed deep-rooted inequalities in Brazil, such as the concentration of healthcare resources in metropolitan areas. Despite the availability of effective vaccines, full immunization coverage was not achieved, allowing cases to progress to severe acute respiratory syndrome (SARS). This study aimed to analyse the progression of mild, moderate, and severe cases between January 2020 and December 2024, covering a five-year period, taking into account regional, social, and variant-related differences, vaccination, and factors associated with SARS due to COVID-19 in Brazil. A total of 47,547,814 influenza-like illness (mild and moderate) cases, 2,127,427 SARS cases due to COVID-19, 533,966,291 vaccination records, and data on circulating variants were analysed. Among the SARS cases, 1,171,801 were confirmed by PCR; 777,672 patients recovered, and 394,129 died, resulting in a case fatality rate of 33.63%. Brazil experienced three major waves of SARS due to COVID-19, with the second wave being the deadliest across all regions. The Gamma and Omicron variants were the most persistent and impactful. The transition between variants influenced the regional dynamics of the pandemic, although little variation was observed in the proportion of circulating variants across regions. The study highlights the importance of continuous monitoring, genomic surveillance, and vaccination coverage to anticipate and mitigate future pandemic waves.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Frontiers in Public Health
140 papers in training set
Top 0.1%
22.2%
2
Epidemiology and Infection
84 papers in training set
Top 0.1%
19.2%
3
PLOS ONE
4510 papers in training set
Top 34%
4.2%
4
Vaccines
196 papers in training set
Top 0.7%
3.5%
5
Journal of Medical Virology
137 papers in training set
Top 1%
3.0%
50% of probability mass above
6
Scientific Reports
3102 papers in training set
Top 42%
3.0%
7
Journal of Clinical Medicine
91 papers in training set
Top 2%
2.8%
8
International Journal of Infectious Diseases
126 papers in training set
Top 1%
1.8%
9
BMC Public Health
147 papers in training set
Top 4%
1.7%
10
Environmental Research
46 papers in training set
Top 0.9%
1.7%
11
The Lancet Regional Health - Western Pacific
15 papers in training set
Top 0.1%
1.6%
12
Travel Medicine and Infectious Disease
15 papers in training set
Top 0.2%
1.6%
13
Microbiology Spectrum
435 papers in training set
Top 3%
1.6%
14
Allergy
23 papers in training set
Top 0.3%
1.5%
15
BMJ Open
554 papers in training set
Top 10%
1.5%
16
The Lancet Regional Health - Americas
22 papers in training set
Top 0.1%
1.3%
17
Emerging Microbes & Infections
74 papers in training set
Top 1%
1.3%
18
EClinicalMedicine
21 papers in training set
Top 0.7%
0.9%
19
PLOS Global Public Health
293 papers in training set
Top 5%
0.9%
20
Frontiers in Medicine
113 papers in training set
Top 6%
0.9%
21
eLife
5422 papers in training set
Top 54%
0.9%
22
International Journal of Environmental Research and Public Health
124 papers in training set
Top 6%
0.9%
23
BMJ Public Health
18 papers in training set
Top 0.6%
0.8%
24
Public Health
34 papers in training set
Top 2%
0.8%
25
The Lancet Regional Health - Europe
32 papers in training set
Top 0.4%
0.7%
26
COVID
13 papers in training set
Top 0.4%
0.7%
27
International Journal of Medical Informatics
25 papers in training set
Top 2%
0.7%
28
BMC Medicine
163 papers in training set
Top 8%
0.7%
29
International Journal of Public Health
17 papers in training set
Top 0.5%
0.7%
30
Frontiers in Microbiology
375 papers in training set
Top 10%
0.6%